What we found on the web about Doripenem
Doripenem is an ultra-broad spectrum injectable antibiotic. It is a beta-lactam and belongs to the subgroup of carbapenems. It was launched by Shionogi Co. of Japan under the brand ...
Doripenem; Panipenem/betamipron; Biapenem; PZ-601. PZ-601 is a carbapenem antibiotic currently being tested as having a broad spectrum of activity including strains resistant to other ...
You should not use this medication if you are allergic to doripenem or imipenem (Primaxin), or a history of allergy to penicillin antibiotics such as Amoxil, Augmentin, Omnipen ...
Organized by therapeutic area, this comprehensive listing of FDA-Approved Drugs by the Food and Drug Administration features facts on clinical trial results, side effects and other ...
Welcome to the DORIBAX ® (doripenem) Formulary Information web site. The information included on this web site has been provided to you in response to your request.
The growing concern for multi-drug resistant organisms has been addressed in previous Pharmacology Consult columns. A review of the newest carbapenem, doripenem, was discussed in ...
Why is this medication prescribed? Return to top. Doripenem injection is used to treat serious infections of the urinary tract, kidney, and abdomen that are caused by ...
Journal of Antimicrobial Chemotherapy 2004 54(1):144-154; doi:10.1093/jac/dkh298 JAC vol.54 no.1 © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved.
FORMULARY DRUG REVIEWS 210 Volume 43, March 2008 Doripenem for Injection Dennis J. Cada, PharmD, FASHP, FASCP* (Editor), Terri Levien, PharmD, † Bhavin Mistry, PharmD, ‡ and ...
Doripenem - DORIBAX™ The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for ...
Here is what users have to say about Doripenem

Doripenem is an ultra-broad spectrum injectable antibiotic. It is a beta-lactam and belongs to the subgroup of carbapenems. It was launched by Shionogi Co. of Japan under the brand name Finibax in 2005, and is being marketed outside Japan by Johnson & Johnson. It is particularly active against Pseudomonas aeruginosa.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!